NLM Logo

Doxorubicin MeSH Descriptor Data 2022


MeSH Heading
Doxorubicin
Tree Number(s)
D02.455.426.559.847.562.050.200.175
D04.615.562.050.200.175
D09.408.051.059.200.175
Unique ID
D004317
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D004317
Scope Note
Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.
Entry Term(s)
Adriablastin
Adriablastine
Adriamycin
Adriblastin
Adriblastina
Adriblastine
Adrimedac
DOXO-cell
Doxolem
Doxorubicin Hexal
Doxorubicin Hydrochloride
Doxorubicin NC
Doxorubicina Ferrer Farm
Doxorubicina Funk
Doxorubicina Tedec
Doxorubicine Baxter
Doxotec
Farmiblastina
Myocet
Onkodox
Ribodoxo
Rubex
Urokit Doxo-cell
Pharm Action
Antibiotics, Antineoplastic
Topoisomerase II Inhibitors
Registry Number
80168379AG
Related Numbers
23214-92-8
25316-40-9
82F2G7BL4E
CAS Type 1 Name
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
NLM Classification #
QV 269
Previous Indexing
Antibiotics, Antineoplastic (1967-1972)
Public MeSH Note
78; see ADRIAMYCIN 1973-77
History Note
78(73)
Date Established
1973/01/01
Date of Entry
1999/01/01
Revision Date
2016/07/05
Doxorubicin Preferred
Farmiblastina Narrower
Ribodoxo Narrower
Rubex Narrower
Adriamycin Narrower
Adriblastin Narrower
Adrimedac Narrower
DOXO-cell Narrower
Doxolem Narrower
Doxorubicin Hexal Narrower
Doxorubicin Hydrochloride Narrower
Doxorubicin NC Narrower
Doxorubicina Ferrer Farm Narrower
Doxorubicina Funk Narrower
Doxorubicina Tedec Narrower
Doxorubicine Baxter Narrower
Doxotec Narrower
Myocet Narrower
Onkodox Narrower
page delivered in 0.167s